Neuphoria Therapeutics Inc (NEUP)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $13.80M
Last updated: Nov 17, 2026 at 11:04 AM ET
Neuphoria Therapeutics Inc (NEUP) Earnings: Report Dates and Results
Neuphoria Therapeutics (NEUP) is expected to report earnings on Nov 18, 2026. In the quarter ended Jun 30, 2026, Neuphoria Therapeutics reported EPS of -$0.13, above the -$0.56 estimate. It beat the EPS estimate in 5 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
NEUP has an expected report date of Nov 18, 2026. No consensus estimate is on file yet for the quarter ending Dec 31, 2026.
Earnings History
Of the 13 quarters below that had an estimate, NEUP beat 6, missed 4 and matched 3. The widest gap in the table came in the quarter ended Sep 30, 2025, when EPS landed 236.64% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | -$0.13 | -$0.56 | -$0.56 - -$0.56 | +76.79% | Beat | N/A | 1 | 0 up, 1 down | Sep 2, 2026 | N/A |
| Mar 31, 2026 | -$0.09 | -$0.56 | -$0.56 - -$0.56 | +83.93% | Beat | -101.4% | 1 | 0 up, 1 down | May 15, 2026 | N/A |
| Dec 31, 2025 | $0.41 | -$0.56 | -$0.56 - -$0.56 | +173.21% | Beat | N/A | 1 | 0 up, 1 down | Feb 17, 2026 | N/A |
| Sep 30, 2025 | -$4.41 | -$1.31 | -$1.31 - -$1.31 | -236.64% | Miss | N/A | 1 | 1 up, 0 down | Nov 14, 2025 | N/A |
| Jun 30, 2025 | -$5.55 | -$3.83 | N/A | -44.91% | Miss | N/A | N/A | 0 up, 0 down | Sep 29, 2025 | N/A |
| Mar 31, 2025 | $6.55 | $6.44 | N/A | +1.71% | Beat | N/A | N/A | 0 up, 0 down | May 20, 2025 | $15.00M |
| Dec 31, 2024 | -$1.23 | N/A | N/A | N/A | N/A | N/A | N/A | 0 up, 0 down | Mar 17, 2025 | $662715 |
| Sep 30, 2024 | $0.00 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 14, 2024 | N/A |
| Jun 30, 2024 | -$0.04 | -$0.66 | N/A | +93.39% | Beat | N/A | N/A | N/A | Aug 21, 2024 | N/A |
| Mar 31, 2024 | -$33.98 | -$0.58 | N/A | N/A | N/A | N/A | N/A | N/A | May 29, 2024 | N/A |
| Dec 31, 2023 | -$0.64 | -$0.63 | N/A | -1.19% | Miss | N/A | N/A | N/A | Mar 30, 2024 | N/A |
| Sep 30, 2023 | Not reported | -$0.59 | N/A | N/A | Not reported | N/A | N/A | N/A | Nov 29, 2023 | N/A |
| Jun 30, 2023 | Not reported | -$0.26 | N/A | N/A | Not reported | N/A | N/A | N/A | Aug 23, 2023 | N/A |
| Mar 31, 2023 | Not reported | -$0.46 | N/A | N/A | Not reported | N/A | N/A | N/A | May 31, 2023 | N/A |
| Dec 31, 2022 | -$0.66 | -$0.66 | N/A | -0.64% | Miss | N/A | N/A | N/A | Feb 22, 2023 | $45371 |
| Sep 30, 2022 | -$0.70 | -$0.70 | N/A | +0.11% | Beat | N/A | N/A | N/A | Nov 30, 2022 | $43023 |
| Jun 30, 2022 | -$97.20 | -$97.20 | N/A | 0.00% | In line | N/A | N/A | N/A | Aug 25, 2022 | N/A |
| Mar 31, 2022 | -$102.60 | -$102.60 | N/A | 0.00% | In line | N/A | N/A | N/A | Jun 1, 2022 | $2.21M |
| Dec 31, 2021 | -$0.51 | -$0.51 | N/A | 0.00% | In line | N/A | N/A | N/A | Feb 22, 2022 | $61380 |
| Sep 30, 2021 | -$0.81 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Dec 1, 2021 | $61281 |
Annual EPS
EPS for the fiscal year ended Jun 30, 2026 was -$4.22, after -$0.24 the year before. It was -$201.12 for the year ended Jun 30, 2022, the oldest of the 5 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Jun 30, 2026 | -$4.22 | N/A |
| Jun 30, 2025 | -$0.24 | N/A |
| Jun 30, 2024 | -$34.66 | N/A |
| Jun 30, 2023 | -$1.36 | N/A |
| Jun 30, 2022 | -$201.12 | N/A |
Frequently Asked Questions About NEUP
When is Neuphoria Therapeutics's next earnings date?
Neuphoria Therapeutics's next earnings report is expected for Nov 18, 2026.
Did NEUP beat earnings estimates last quarter?
Yes. Neuphoria Therapeutics reported EPS of -$0.13 for the quarter ended Jun 30, 2026, above the -$0.56 estimate, a 76.79% surprise.
How often does NEUP beat earnings estimates?
Neuphoria Therapeutics beat the EPS estimate in 5 of the 8 most recent quarters that had an estimate, with an average surprise of +18.29%.
NEUP pages: Overview, Earnings, Forecast, Financials, Competitors